NCT04250805 2024-01-31
GASTROXY
Centre Hospitalier Universitaire de Saint Etienne
Phase 2 Terminated
Clinical Trials
13 trialsNCT00351715 2019-10-21
Sublingual Methadone for the Management of Cancer-related Breakthrough Pain in Outpatients
AHS Cancer Control Alberta
Phase 2 Terminated
NCT03407430 2018-06-26
Trial of Pregabalin for Granulocyte Colony-stimulating Factor (GCSF)-Induced Bone Pain
UNC Lineberger Comprehensive Cancer Center
Phase 2 Terminated
NCT01921296 2016-04-20
Pilot Study of Cyclobenzaprine for Treatment of Sleep Disturbance in Aromatase Inhibitor-treated Breast Cancer Patients
University of Michigan Rogel Cancer Center
Phase 2 Terminated
NCT00558870 2016-04-05
Role of Methadone As Co-Opioid Analgesic
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT00573937 2016-02-19
Methadone Versus Morphine for Cancer-Related Pain
Mayo Clinic
Phase 2 Terminated
NCT01931865 2015-12-31
IncobotulinumtoxinA for Treatment of Focal Cancer Pain After Surgery and/or Radiation
Yale University
Phase 2 Terminated
NCT01047774 2015-10-07
The Effect of Soy Protein on Post- Breast Cancer Surgery Pain
McGill University Health Centre/Research Institute of the McGill University Health Centre
Phase 2 Terminated
NCT01439919 2013-03-21
ACT11705
Sanofi
Phase 2 Terminated
NCT00684242 2013-01-28
Lenalidomide (Revlimid) for the Treatment of Refractory Cancer Pain
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT00351637 2012-01-19
Sublingual Methadone for the Management of Cancer-related Procedure Pain in Inpatients
AHS Cancer Control Alberta
Phase 2 Terminated
NCT00892268 2010-04-27
Acupuncture or Medication in Reducing Pain in Postmenopausal Women With Breast Cancer and Joint Pain
University of Arizona
Phase 2 Terminated
NCT00101621 2006-02-09
Pilot Study to Evaluate the Safety and Analgesic Activity of M40403 Co-Administered With an Opioid Agent for Cancer Pain
MetaPhore Pharmaceuticals
Phase 2 Terminated